Health research in England - funding, regulation and priorities for future policy and support

26/03/2020

Stakeholders in health research and policymakers will discuss:

  • the future of cross-border collaboration - particularly with the EU on scientific research, including Horizon;
  • the balance of public and private sector funding - including the impact of any changes to the funding landscape;
  • regulation of clinical trials as the EU prepares to implement Clinical Trials Regulation (CTR); and
  • what more needs to be done to ensure the UK remains an attractive place to carry out research.

London, UK

More information

Ask for a Free trial and get access to the latest stories

Our coverage includes:
  • Health Care
  • Market Access
  • HTA – policies & practices
  • European medicine regulations
  • Drug safety issues
  • Pricing & Reimbursement
  • International medicines agencies

If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.

REQUEST

an initial 10 day temporary access of APM Health Europe.